Claudia Klein
Bonn, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Treatment With Valoctocogene Roxaparvovec in a Patient With Severe Hemophilia A Led to Sustained Normal FVIII Levels.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: October 22, 2025
Comprehensive evaluation of anti-emicizumab antibodies in acquired hemophilia A: a detailed case study and methodological evaluation.
Journal: Journal of thrombosis and haemostasis : JTH
Published: June 19, 2024
Comprehensive laboratory assessment of lonoctocog alfa versus octocog alfa in severe haemophilia A.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: June 03, 2024
Functional determination of emicizumab in presence of factor VIII activity.
Journal: Journal of thrombosis and haemostasis : JTH
Published: August 17, 2023
Antidrug antibodies against the polyethylene glycol moiety inhibit the procoagulant activity of therapeutic polyethylene glycolated factor VIII.
Journal: Journal of thrombosis and haemostasis : JTH
Published: September 23, 2022
Most subjectively affected joints in patients with haemophilia - what has changed after 20 years in Germany?
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: January 21, 2022
Transverse melanonychia (TM): induced by radiotherapy.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: December 30, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026